Scientists in Bristol have worked with CliniSys to develop information technology (IT) to support critical newborn screening and tissue typing services.
Experts working for Severn Pathology at North Bristol NHS Trust have helped to create new modules for the WinPath Enterprise laboratory information system to support the delivery of the National Newborn Blood Spot Screening Programme and donor-recipient matching for organ donation.
David Brixey (pathology and IM&T manager at North Bristol NHS Trust) said: “There are very few systems out there to support these services, so we were delighted that CliniSys was willing to work with us to develop these new modules from scratch.
“CliniSys has really taken the time to get to understand the intricacies of how these services work and what they need from technology. Staff have found it easy to transition to the new system and it is already making a difference to services that have a huge impact on people’s lives.”
Severn Pathology is an innovative pathology network that brings together the laboratory services of four major acute trusts. It is based at Southmead Hospital in Bristol, part of North Bristol NHS Trust, but serves health services across the south-west and beyond.
The network has been using WinPath Enterprise as a single laboratory information management system (LIMS) since 2016 and went live with the newborn screen and tissue typing modules in September.
